Stuart Evans, partner at law firm BLM and specialist in commercial disputes and litigation examines the origins and fallout of the EU/AstraZeneca vaccine dispute and why the twin forces of COVID-19 and Brexit seem set to muddy the waters of cross-border pharma trade for some time to come.   Five months on from the first … Continue reading Vaccine Wars: What the EU/AstraZeneca Row Shows Us About Pharma Cross-Border Litigation